Caribou Biosciences, Inc.
Clinical trials sponsored by Caribou Biosciences, Inc., explained in plain language.
-
Lupus Gene-Tweak therapy trial pulled before it began
Disease control TerminatedThis study was designed to test a single infusion of CB-010, a CRISPR-edited immune cell therapy, in people with severe lupus that did not respond to standard treatments. The trial was withdrawn before enrolling any participants, so no results are available. It aimed to check saf…
Phase: PHASE1 • Sponsor: Caribou Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study tracks 150 people who previously received Caribou cell therapy for blood cancers like lymphoma or leukemia. The goal is to watch for long-term side effects and safety issues over 15 years. No new treatment is given—just regular check-ups to see how patients are doing.…
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC